SCNI Scinai Immunotherapeutics Ltd.

$SCNI Is this an offering or insiders selling? I’m gambling a few hundred bucks on this thing.

$SCNI offering $.45 per share Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing $.45 per share

$SCNI It looks like an Head and Shoulder on 5' chart at breakout of neckline 1.38 ----target 1.48 then 1.57-1.6

$SCNI only down 56% in one week. Company is a dumpster fire, and I have no confidence in what they say. It's the usual path: colorful slides, executive salary, dilution, repeat...

🌅 Watchlist part 2 ✅ $SCNI 1.50 support, above 1.80, potential to 2.2/2.5 ✅ $AIXI low 3 support, above 3.5, potential to 3.8/4.5 ✅ $YJ 2.20 support, above 2.65, potential to 3/3.5 ✅ $WBUY ideal breakout if above 1 🎯 Ideal stop loss below current support 🚨 Avoid chasing long positions into strength near resistance 🎯🎯 Goal is GR🤑🤑N, not GR🥵🥵D

$SCNI faded hard from it's initial gap up, but I'm keeping this on my radar in case it begins to break over it's lower high structure and the 1m 50EMA. Range to $2.00 and VWAP on the curl, but as always, no break, no trade!

$SCNI With these corporate developments, hitting a 52-week high isn’t out of the question. I added

$SCNI company is horribly managed. Either through gross incompetence and/or being scamminess, they milked their worthless universal flu vaccination for 15+ years (endless phase 2 tests), only for it to be effective as salt water. Expect colorful slides and more placements forthcoming.

$SCNI offering $.45 per share Scinai Immunotherapeutics Announces $2.61 Million Private Placement Financing $.45 per share

$SCNI 💰 Scinai Immunotherapeutics Ltd. closes a $4.0 million private placement and warrant inducement, issuing 2,458,334 ADSs and Series A-1 Warrants for up to 3,687,501 ADSs and exercising 879,194 existing warrants at $1.20 per ADS. Selected from hundreds of headlines

$SCNI lets see tomorrow $YFOR tomorrow new day $EPSM where the slaps will pay very soon, china bottom

$SCNI The only way or mindset to trade these shit stocks: NO GREED NO DREAMS OR STUPID ILLUSIONS NO HOPES NO REVENGE TRADING NO OVERTRDING NEVER FALLING IN LOVE WITH TRASH STOCK FAST FAST TRADING DISCIPLINE AND MONEY MANAGEMENT STRATEGY ON THE CONTRARY you will quickly burn your trading account 30 years of trading experience 😱😱😱😂😍

$SCNI — Significant relative-volume expansion in a small biotech. Scinai Immunotherapeutics is showing unusually active trading, with more than 51 million shares traded in today’s available snapshot. The company has been developing immunology-focused technologies while exploring opportunities around its biologics development capabilities. For microcap biotechs, the biggest factors are often funding, partnerships and the ability to advance programs without excessive shareholder dilution. The elevated volume makes this interesting from a momentum perspective, but I’m looking for concrete corporate developments before drawing conclusions about its longer-term value.

$SCNI Genius...What do you think about the SCNI crash?You were extremely bullish two days ago 🫣🫣🫣🫣😱😂

$SCNI 160% Incoming from HOD, Attention is dispersed among other stocks currently moving at higher cost basis, wait for those stocks to flush and soon Retail will come back to this one. Nice ROI on this one.

$SCNI When you sell you provide liquidity for bigger buyers, it will continue to absorb your selling shares before it moves upwards.

$SCNI Committed Customer Orders¹ reach approximately $7.6 million, up approximately 300% from $1.9 million at year-end 2025 Agreement with a U.S. based, Nasdaq-listed biopharmaceutical company supports development activity in 2026 and clinical manufacturing planned for 2027 Potential additional clinical manufacturing carries an indicative, uncommitted service-fee value of ** $5.85 million for late 2027** through the first half of 2028, excluding additional scale-up, qualification and initial manufacturing activities not yet priced.

$SCNI Hey, saw the SCNI news. They signed a $5.1M development and clinical manufacturing deal with a U.S. biopharma company. Committed orders are now around $7.6M (up significantly from year-end). This is real contracted revenue, not just a partnership. Stock is up in premarket, but it’s been choppy and not holding. Shorts have been active and can easily fade these microcaps, even with positive news. Short interest was high, so some pressure makes sense.

$SCNI That said, exercise is still optional. Even if the stock rises above the strike, holders may choose not to exercise, and the company only receives cash if they do. So the warrants are a potential dilution overhang—not guaranteed dilution.

$SCNI: Scinai Immunotherapeutics (+58.6%) secured a $5.1 million development and clinical manufacturing agreement, lifting committed customer orders to approximately $7.6 million.